Cargando…

Is There a “Blind Spot” in Point-of-Care Testing for Residual Heparin After Cardiopulmonary Bypass? A Prospective, Observational Cohort Study

Identifying the cause of a bleeding complication after cardiac surgery can be crucial. This study sought to clarify whether the application of unprocessed autologous pump blood influences anti-factor Xa activity after cardiac surgery and evaluated 2 point-of-care methods regarding their ability to i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wand, Saskia, Heise, Daniel, Hillmann, Nadine, Bireta, Christian, Bräuer, Anselm, von Ahsen, Nicolas, Quintel, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Manuscript
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430071/ https://www.ncbi.nlm.nih.gov/pubmed/32795187 http://dx.doi.org/10.1177/1076029620946843

Ejemplares similares

Recombinant activated factor VII (Novo7(®)) in patients with ventricular assist devices: Case report and review of the current literature
por: Heise, Daniel, et al.
Publicado: (2007)

Lepirudin as an alternative to "heparin allergy" during cardiopulmonary bypass
por: Parissis, Haralabos
Publicado: (2011)

Bivalirudin for cardiopulmonary bypass in a patient with heparin allergy
por: Boysan, Emre, et al.
Publicado: (2023)

Identification of ferroptosis-associated genes exhibiting altered expression in response to cardiopulmonary bypass during corrective surgery for pediatric tetralogy of fallot
por: Liu, Hongtao, et al.
Publicado: (2021)

Potency Adjusted Blended Heparin of Bovine, Ovine, and Porcine Heparin Exhibit Comparable Biologic Effects to Referenced Single-Sourced Porcine Heparin
por: Olson, Guy, et al.
Publicado: (2023)

Association between perioperative hypothermia and patient outcomes after thoracic surgery: A single center retrospective analysis
por: Emmert, Alexander, et al.
Publicado: (2018)

Does sodium bicarbonate infusion really have no effect on the incidence of acute kidney injury after cardiac surgery? A prospective observational trial
por: Wetz, Anna J, et al.
Publicado: (2015)

Heparin Resistance During Cardiopulmonary Bypass in Adult Cardiac Surgery
por: Chen, Yufan, et al.
Publicado: (2022)

Association Between Thrombin–Antithrombin Complex and Acute Kidney Injury After Pediatric Cardiopulmonary Bypass Surgery: A Single-Center Retrospective Observational Study
por: Minami, Sakura, et al.
Publicado: (2023)

Patients’ Plasma Activity of Heparin, low-Molecular-Weight Heparin or no Anticoagulants on Urine Based DOAC Test Strips
por: Harenberg, Job, et al.
Publicado: (2022)

Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa
por: Lewis, Joseph, et al.
Publicado: (2022)

Cardiopulmonary Bypass Surgery in a Patient with Unexpected Heparin-Induced Thrombocytopenia
por: Miyagawa, Atsushi, et al.
Publicado: (2022)

How to Solve the Conundrum of Heparin-Induced Thrombocytopenia during Cardiopulmonary Bypass
por: Revelly, Etienne, et al.
Publicado: (2023)

Quantification of urinary TIMP-2 and IGFBP-7: an adequate diagnostic test to predict acute kidney injury after cardiac surgery?
por: Wetz, Anna J, et al.
Publicado: (2015)

Low-molecular-weight heparin-coated cardiopulmonary bypass: coagulatory and clinical findings
por: Mirow, N, et al.
Publicado: (2001)

Cardiopulmonary bypass using heparin surface treatment: influence on memory and neurological deviations
por: Svenmarker, S, et al.
Publicado: (2000)

Pharmacokinetic model of unfractionated heparin during and after cardiopulmonary bypass in cardiac surgery
por: Jia, Zaishen, et al.
Publicado: (2015)

NGAL expression during cardiopulmonary bypass does not predict severity of postoperative acute kidney injury
por: Friedrich, Martin G., et al.
Publicado: (2017)

In-hospital Mortality Rates in SARS-CoV-2 Patients Treated with Enoxaparin and Heparin
por: Alroomi, Moudhi, et al.
Publicado: (2022)

Edoxaban Versus Low-Molecular-Weight Heparin in Hospitalized COVID-19 Patients With Atrial Fibrillation
por: Olivera, Pável, et al.
Publicado: (2023)

Predictive Factors and Clinical Events Associated with Edoxaban Interruption and Heparin Bridging Strategy: EMIT-AF/VTE
por: Santamaria, Amparo, et al.
Publicado: (2023)

Close to me but unreachable: spotting the link between peripersonal space and empathy
por: Schiano Lomoriello, Arianna, et al.
Publicado: (2023)

Whole-blood Point-of-Care Activated Partial Thromboplastin Time Ratio (APR) is not Accurate Enough to Monitor Heparin Therapy in Patients with Severe Respiratory Failure Secondary to SARS-Cov-2 Infection Supported with Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO)
por: Aston, Daniel, et al.
Publicado: (2022)

Abrupt formation of intracardiac thrombus during cardiopulmonary bypass with full heparinization -A case report-
por: Kim, Seong-Hyop, et al.
Publicado: (2012)

Risk Factors Associated with Difficult Reversal of Heparin by Protamine Sulfate in Cardiopulmonary Bypass: An Ignored Issue
por: Ku, Min Jung, et al.
Publicado: (2020)

Incidence, Outcomes and Risk Factors of Heparin-Induced Thrombocytopenia After Total Joint Arthroplasty: A National Inpatient Sample Database Study
por: Chen, Yuhang, et al.
Publicado: (2021)

The effects on coagulation of the reinfusion of unprocessed residual blood from the cardiopulmonary bypass
por: Iyer, Yolande-Leigh, et al.
Publicado: (2016)

Optimization of Chelex 100 resin-based extraction of genomic DNA from dried blood spots
por: Simon, Neta, et al.
Publicado: (2020)

Rivaroxaban Versus Low-Molecular-Weight Heparins in a Broad Cohort of Patients With Cancer-Associated Venous Thromboembolism: An Analysis of the OSCAR-US Program
por: Caroti, Kimberly Snow, et al.
Publicado: (2023)

Cardiopulmonary Bypass
por: Rondelez, Luc, et al.
Publicado: (2010)

Is the precise control of circulating heparin levels during cardiopulmonary bypass beneficial in paediatric open-heart surgery?
por: Codispoti, M, et al.
Publicado: (1999)

Anticoagulation Management and Heparin Resistance During Cardiopulmonary Bypass: A Survey of Society of Cardiovascular Anesthesiologists Members
por: Sniecinski, Roman M., et al.
Publicado: (2019)

A Blinded Randomized Trial Comparing Standard Activated Clotting Time Heparin Management to High Target Active Clotting Time and Individualized Hepcon HMS Heparin Management in Cardiopulmonary Bypass Cardiac Surgical Patients
por: Nuttall, Gregory A., et al.
Publicado: (2021)

Safety Comparison of Monotherapy Aspirin to Dual Antiplatelet Therapy Following Coronary Artery Bypass Surgery
por: Nei, Scott D., et al.
Publicado: (2022)

Does transfusion of residual cardiopulmonary bypass circuit blood increase postoperative bleeding? A prospective randomized study in patients undergoing on pump cardiopulmonary bypass
por: Duara, Rajnish, et al.
Publicado: (2008)

Clinical governance breakdown: Australian cases of wilful blindness and whistleblowing
por: Cleary, Sonja, et al.
Publicado: (2017)

A prospective, blinded evaluation of a video-assisted ‘4-stage approach’ during undergraduate student practical skills training
por: Schwerdtfeger, Katrin, et al.
Publicado: (2014)

Basics of cardiopulmonary bypass
por: Sarkar, Manjula, et al.
Publicado: (2017)

A Single-Center Bleeding Comparison of Warfarin Plus Aspirin or Clopidogrel Following Coronary Artery Bypass Grafting and Surgical Valve Replacement
por: Zieminski, Joseph J., et al.
Publicado: (2023)

Protamine dose to neutralize heparin at the completion of cardiopulmonary bypass can be reduced significantly without affecting post-operative bleeding
por: Lee, Min-Ho, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_iqrkneqp1o1liattv64h07jlkt